A recent observational study from the UK raises questions over the control of mineral metabolism parameters to within target levels defined by the KDOQI clinical practice guidelines. Data from this study highlight the need for a randomized controlled trial to determine whether optimal management of bone mineral metabolism actually provides any survival benefit.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Block, G. A., Hulbert-Shearon, T. E., Levin, N. W. & Port, F. K. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am. J. Kidney Dis. 31, 607–617 (1998).
Kalantar-Zadeh, K. et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 70, 771–780 (2006).
Wald, R. et al. Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) study. Am. J. Kidney Dis. 52, 531–540 (2008).
Kidney Disease: Improving Global Outcomes (KDIGO) CKD–MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int. Suppl. 113, S1–S130 (2009).
Tangri, N. et al. Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom renal registry. Am. J. Kidney Dis. doi:10.1053/j.ajkd.2010.08.037.
Wolf, M. et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 72, 1004–1013 (2007).
Isakova, T. et al. Phosphorus binders and survival on hemodialysis. J. Am. Soc. Nephrol. 20, 388–396 (2009).
Danese, M. D., Belozeroff, V., Smirnakis, K. & Rothman, K. J. Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin. J. Am. Soc. Nephrol. 3, 1423–1429 (2008).
Drüeke, T. B. et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N. Engl. J. Med. 355, 2071–2084 (2006).
Appel, L. J. et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N. Engl. J. Med. 363, 918–929 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
H. Komaba declares associations with Chugai Pharmaceutical and Kyowa Hakko Kirin. M. Fukagawa declares associations with Bayer Yakuhin, Chugai Pharmaceutical and Kyowa Hakko Kirin.
Rights and permissions
About this article
Cite this article
Komaba, H., Fukagawa, M. Is the road to survival paved with good mineral management?. Nat Rev Nephrol 7, 185–186 (2011). https://doi.org/10.1038/nrneph.2011.25
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2011.25